LT3669B - Preparation process of solid pharmaceutical forms and such forms - Google Patents

Preparation process of solid pharmaceutical forms and such forms Download PDF

Info

Publication number
LT3669B
LT3669B LTIP903A LTIP903A LT3669B LT 3669 B LT3669 B LT 3669B LT IP903 A LTIP903 A LT IP903A LT IP903 A LTIP903 A LT IP903A LT 3669 B LT3669 B LT 3669B
Authority
LT
Lithuania
Prior art keywords
ebselen
forms
dosage forms
solid dosage
benzisoselenazol
Prior art date
Application number
LTIP903A
Other languages
English (en)
Lithuanian (lt)
Inventor
Juergen Seidel
Axel Roemer
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of LTIP903A publication Critical patent/LTIP903A/xx
Publication of LT3669B publication Critical patent/LT3669B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D293/12—Selenazoles; Hydrogenated selenazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
LTIP903A 1987-06-20 1993-08-30 Preparation process of solid pharmaceutical forms and such forms LT3669B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873720493 DE3720493A1 (de) 1987-06-20 1987-06-20 Arzneizubereitungen mit mikronisierten ebselen-kristallen

Publications (2)

Publication Number Publication Date
LTIP903A LTIP903A (en) 1995-03-27
LT3669B true LT3669B (en) 1996-01-25

Family

ID=6330016

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP903A LT3669B (en) 1987-06-20 1993-08-30 Preparation process of solid pharmaceutical forms and such forms

Country Status (25)

Country Link
US (1) US5021242A (fi)
EP (1) EP0296389B1 (fi)
JP (1) JPH0713016B2 (fi)
KR (1) KR970005322B1 (fi)
AT (1) ATE69165T1 (fi)
AU (1) AU603454B2 (fi)
CA (1) CA1310906C (fi)
DD (1) DD271056A5 (fi)
DE (2) DE3720493A1 (fi)
DK (1) DK173628B1 (fi)
ES (1) ES2041736T3 (fi)
FI (1) FI88256C (fi)
GE (1) GEP19960342B (fi)
GR (1) GR3003084T3 (fi)
HU (1) HU200096B (fi)
IE (1) IE63512B1 (fi)
LT (1) LT3669B (fi)
LV (1) LV10381B (fi)
MX (1) MX169170B (fi)
NO (1) NO175133C (fi)
NZ (1) NZ225066A (fi)
PT (1) PT87767B (fi)
RU (1) RU1834657C (fi)
UA (1) UA12648A (fi)
ZA (1) ZA884025B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368864A (en) * 1988-11-25 1994-11-29 Henning Berlin Gmbh Chemie- Und Pharmawerk Formulation of oxypurinol and/or its alkali and alkaline earth salts
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP2553434B2 (ja) * 1992-04-28 1996-11-13 第一製薬株式会社 粒状製剤
RU2143898C1 (ru) * 1993-10-27 2000-01-10 Дайити Фармасьютикал Ко., Лтд. Гранулированный фармацевтический препарат и водная суспензия на его основе
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
AU701042B2 (en) * 1995-02-28 1999-01-21 Aventisub Llc Pharmaceutical composition for piperidinoalkanol compounds
EE04294B1 (et) * 1997-08-26 2004-06-15 Hoechst Marion Roussel, Inc. Farmatseutiline kompositsioon piperidinoalkanooldekongestandi kombineerimiseks
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
US7671211B1 (en) 1999-03-31 2010-03-02 Arne Holmgren Substrates for thioredoxin reductase
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
JP2006518754A (ja) * 2003-02-24 2006-08-17 マリンクロッド・インコーポレイテッド ベンズヒドリルチオアセトアミドの改良製法
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
WO2008148064A1 (en) * 2007-05-23 2008-12-04 Sunesis Pharmaceuticals, Inc. Weight loss treatment
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
TW201613888A (en) 2014-09-26 2016-04-16 Helsinn Healthcare Sa Crystalline forms of an NK-1 antagonist
WO2022167778A1 (en) * 2021-02-02 2022-08-11 Haiku Therapeutics Ltd Ebselen as adenosine receptor modulator
WO2023240092A1 (en) * 2022-06-06 2023-12-14 Sound Pharmaceuticals Inc. Ebselen containing oral dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3407511A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen

Also Published As

Publication number Publication date
NZ225066A (en) 1990-07-26
FI88256C (fi) 1993-04-26
ZA884025B (en) 1988-12-20
GR3003084T3 (en) 1993-02-17
NO882615L (no) 1988-12-21
AU1811688A (en) 1988-12-22
FI882912A (fi) 1988-12-21
DK173628B1 (da) 2001-05-07
KR970005322B1 (ko) 1997-04-15
FI882912A0 (fi) 1988-06-17
MX169170B (es) 1993-06-23
NO175133B (no) 1994-05-30
DE3866033D1 (de) 1991-12-12
NO175133C (no) 1994-09-07
ATE69165T1 (de) 1991-11-15
LTIP903A (en) 1995-03-27
DE3720493A1 (de) 1989-01-26
HU200096B (en) 1990-04-28
GEP19960342B (en) 1996-02-20
HUT50037A (en) 1989-12-28
IE881628L (en) 1988-12-20
RU1834657C (ru) 1993-08-15
FI88256B (fi) 1993-01-15
EP0296389A1 (de) 1988-12-28
EP0296389B1 (de) 1991-11-06
NO882615D0 (no) 1988-06-14
JPH0713016B2 (ja) 1995-02-15
PT87767A (pt) 1989-05-31
DK333388D0 (da) 1988-06-17
LV10381A (lv) 1995-02-20
PT87767B (pt) 1992-10-30
ES2041736T3 (es) 1996-07-16
AU603454B2 (en) 1990-11-15
KR890000084A (ko) 1989-03-11
IE63512B1 (en) 1995-05-03
US5021242A (en) 1991-06-04
CA1310906C (en) 1992-12-01
LV10381B (en) 1995-06-20
DK333388A (da) 1988-12-21
DD271056A5 (de) 1989-08-23
JPH01100125A (ja) 1989-04-18
UA12648A (uk) 1997-02-28

Similar Documents

Publication Publication Date Title
LT3669B (en) Preparation process of solid pharmaceutical forms and such forms
SU1443788A3 (ru) Способ получени твердой лекарственной формы
FR2602423A1 (fr) Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
EP0233559A1 (en) Readily absorbable pharmaceutical composition
JPS5914446B2 (ja) ニフエジピン含有固形製剤及びその製造方法
JPH0148884B2 (fi)
AU1211992A (en) Low dose dry pharmaceutical preparations
AU729437B2 (en) Cefadroxil monohydrate tablet formulation
EP1294372B1 (en) Dry powder formulation comprising racecadotril
US7666860B2 (en) Melt-formulated, multi-particulate oral dosage form
JP2000515559A (ja) 体重減量方法
US4526777A (en) Pharmaceutical combination composition and associated method
US20050171070A1 (en) Stable salts of o-acetylsalicylic acid containing basic amino acids II
US4954505A (en) Use of oxoquinazoline derivatives in the treatment of hyperuricaemia
CA2417918A1 (en) Compositions containing an inhibitor of dihydrofolate reductase and a folate
JPS5925765B2 (ja) 消化性潰瘍治療剤
CN113440614A (zh) 一种用于治疗类风湿性关节炎的组合物及其应用
CA2225674A1 (en) Therapeutic effervescent compositions
EP0091179B1 (en) Synergistic antiphlogistic compositions and process for the preparation thereof
JPH0643337B2 (ja) コリン・アセチル転移酵素活性賦活剤
JPH0344320A (ja) ｐ―［２―（５，６，７，８―テトラヒドロ―５，５，８，８―テトラメチル―２―ナフチル）プロペニル］フエノールの医薬としての使用
WO1987000428A1 (en) Oxazepam containing pharmaceutical composition
Ono et al. Biochemical studies on the pathogenesis of steroid cataracts, with particular reference to the pituitary-adrenal-liver axis
CN101062047B (zh) 一种含有异甘草酸和苦参素的组合物及其用途
JPH02193928A (ja) 抗高脂血症剤

Legal Events

Date Code Title Description
MK9A Expiry of a patent

Effective date: 20130830